
The United States Patent and Trademark Office (USPTO) significantly increased its trademark fees in January 2025, introducing new cost structures and a notable $200 per-class surcharge for any application using a “custom ID.” This change directly affects hemp and cannabidiol (CBD) businesses, which are often compelled to use custom wording in trademark applications—usually to reference compliance or clarify lawful use. As the legal landscape for cannabis continues to shift, particularly with potential federal rescheduling of marijuana, stakeholders across the hemp and CBD sectors must update their trademark and compliance strategies.
This post breaks down what the new USPTO fees mean for cannabis businesses, how to draft goods and services IDs to minimize costs and exposure, and why your overall compliance and branding strategy needs to evolve.
Key changes effective January 18, 2025 (Source: USPTO):
Why are hemp and CBD brands especially affected? The USPTO’s ID Manual currently lacks standard wording for many hemp- and CBD-related goods. Applicants referencing CBD, hemp, or delta-8 explicitly—especially for ingestibles or non-topical products—frequently trigger ‘lawful use’ refusals, requiring custom ID language to clarify federal compliance. The fee hike penalizes transparency and legal caution.
Since most hemp and CBD ingestibles remain unlawful under the Food, Drug & Cosmetic Act (FDCA), applications referencing “CBD gummies,” “CBD tinctures,” or similar will nearly always:
Strategies to minimize cost and risk:
For the ID Manual: Check USPTO Trademark ID Manual for the latest accepted descriptions.
As of September 2025, no final federal rule has fully rescheduled marijuana from Schedule I to Schedule III, though the Department of Justice is moving toward this change. Even if finalized, rescheduling will NOT automatically legalize food or supplement uses of cannabis or CBD under the FDCA (see Federal Cannabis Trademark Trends 2025).
Key takeaways:
USPTO maintains its “Intent-To-Use” (ITU) filing option for brands intending future product launches (More: USPTO ITU Guide). For CBD and hemp companies, filing an ITU application lets you stake a claim to a brand name in advance—especially important given regulatory flux.
Practical steps post-2025:
Higher TTAB fees mean disputes—both offensive and defensive—are now pricier. Enforcement strategies in 2025 should focus on:
Read more on TTAB fees and procedures.
Hemp beverage and topical brands increasingly look to packaging and overall look-and-feel (“trade dress”) for extra IP protection. USPTO scrutiny is increasing, so:
Brand protection shouldn’t outpace compliance. Work with compliance professionals to:
As the regulatory and trademark landscape for hemp and CBD products continues to evolve, informed, compliant, and strategic protection is more important than ever. For detailed tracking of federal and state law, compliance updates, and practical guidance, visit CannabisRegulations.ai and ensure your brand keeps pace—and stays protected.

The United States Patent and Trademark Office (USPTO) significantly increased its trademark fees in January 2025, introducing new cost structures and a notable $200 per-class surcharge for any application using a “custom ID.” This change directly affects hemp and cannabidiol (CBD) businesses, which are often compelled to use custom wording in trademark applications—usually to reference compliance or clarify lawful use. As the legal landscape for cannabis continues to shift, particularly with potential federal rescheduling of marijuana, stakeholders across the hemp and CBD sectors must update their trademark and compliance strategies.
This post breaks down what the new USPTO fees mean for cannabis businesses, how to draft goods and services IDs to minimize costs and exposure, and why your overall compliance and branding strategy needs to evolve.
Key changes effective January 18, 2025 (Source: USPTO):
Why are hemp and CBD brands especially affected? The USPTO’s ID Manual currently lacks standard wording for many hemp- and CBD-related goods. Applicants referencing CBD, hemp, or delta-8 explicitly—especially for ingestibles or non-topical products—frequently trigger ‘lawful use’ refusals, requiring custom ID language to clarify federal compliance. The fee hike penalizes transparency and legal caution.
Since most hemp and CBD ingestibles remain unlawful under the Food, Drug & Cosmetic Act (FDCA), applications referencing “CBD gummies,” “CBD tinctures,” or similar will nearly always:
Strategies to minimize cost and risk:
For the ID Manual: Check USPTO Trademark ID Manual for the latest accepted descriptions.
As of September 2025, no final federal rule has fully rescheduled marijuana from Schedule I to Schedule III, though the Department of Justice is moving toward this change. Even if finalized, rescheduling will NOT automatically legalize food or supplement uses of cannabis or CBD under the FDCA (see Federal Cannabis Trademark Trends 2025).
Key takeaways:
USPTO maintains its “Intent-To-Use” (ITU) filing option for brands intending future product launches (More: USPTO ITU Guide). For CBD and hemp companies, filing an ITU application lets you stake a claim to a brand name in advance—especially important given regulatory flux.
Practical steps post-2025:
Higher TTAB fees mean disputes—both offensive and defensive—are now pricier. Enforcement strategies in 2025 should focus on:
Read more on TTAB fees and procedures.
Hemp beverage and topical brands increasingly look to packaging and overall look-and-feel (“trade dress”) for extra IP protection. USPTO scrutiny is increasing, so:
Brand protection shouldn’t outpace compliance. Work with compliance professionals to:
As the regulatory and trademark landscape for hemp and CBD products continues to evolve, informed, compliant, and strategic protection is more important than ever. For detailed tracking of federal and state law, compliance updates, and practical guidance, visit CannabisRegulations.ai and ensure your brand keeps pace—and stays protected.